Methylprednisolone

甲泼尼龙

Report date: 2026/05/14 20:00:28
NME

Base Information

Drug NameMethylprednisolone
Drug Alias NameMethylprednisolonumMetilprednisolonaMethylprednisolonUrbasonNSC-19987
ClassificationSmall molecules > Steroids
Mechanisms of ActionGlucocorticoid receptor agonists
TargetsGlucocorticoid receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Neuroinflammatory DiseasesPost-Acute COVID-19 Syndrome +[67
Global Approved IndicationsInflammation
Approved Indications in ChinaInflammation
Original Approved Country/TerritoryUnited States
Original Approved Date1957/10/24
Country/TerritoryBelgiumCanadaUnited States +[23
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesPharmacia & Upjohn
China Registration ClassN/A

Develop Information

Active IndicationsNeuroinflammatory DiseasesChronic PainInflammation +[37
Inactive IndicationsCoronavirus Disease 2019 (COVID-19)Post-Acute COVID-19 SyndromeVomiting +[30

Other Information

ATC CodeD07AA01D10AA02H02AB04